Trademark Overview
On Friday, March 14, 2025, a trademark application was filed for ADBALYA with the United States Patent and Trademark Office. The USPTO has given the ADBALYA trademark a serial number of 99084951. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 14, 2025. This trademark is owned by AstraZeneca AB. The ADBALYA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Pharmaceutical preparations for the treatment of antibodies; Vaccines